Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study

INTRODUCTION: Cladribine is approved for the treatment of active relapsing MS (RRMS), but its positioning in MS therapeutic scenario still needs to be fully elucidated. METHODS: This is a monocentric, observational, real-world study on RRMS patients treated with cladribine. Relapses, magnetic resona...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanetta, Chiara, Rocca, Maria A., Meani, Alessandro, Martinelli, Vittorio, Ferrè, Laura, Moiola, Lucia, Filippi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080181/
https://www.ncbi.nlm.nih.gov/pubmed/37027018
http://dx.doi.org/10.1007/s00415-023-11700-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080181/
https://www.ncbi.nlm.nih.gov/pubmed/37027018
http://dx.doi.org/10.1007/s00415-023-11700-7

Ejemplares similares